ReviewCureus2025
Tonsillar Hypertrophy in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma: A Mini-Review.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic lymphocytic leukemia (CLL) is a prevalent adult B-cell malignancy that primarily affects individuals over the age of 65. It is characterized by the accumulation of mature B lymphocytes in the blood and bone marrow, whereas small lymphocytic lymphoma (SLL) primarily involves the lymph nodes and lymphoid tissues, with minimal lymphocytosis in the blood. Both CLL and SLL are recognized as a single entity according to iwCLL guidelines. Tonsillar hypertrophy is a rare presentation of CLL and often an overlooked complication. We searched PubMed, Scopus, Semantic Scholar, and Google Scholar up to November 8, 2025, for patients with CLL or SLL and tonsillar enlargement. We identified 14 published cases of CLL/SLL with tonsillar enlargement. The review aims to highlight clinical features, diagnostic challenges, and outcomes. Most patients presented with dysphagia, airway obstruction, or obstructive sleep apnea. Diagnosis frequently required tonsillectomy, followed by histopathology, flow cytometry, and fluorescence in situ hybridization. Management strategies included observation, tonsillectomy for symptom relief and diagnosis, systemic chemoimmunotherapy, or targeted agents such as BTK inhibitors. Most patients achieved remission or symptom improvement; however, a few cases resulted in death due to rapidly progressive disease. This review highlights the importance of considering CLL in adults with unexplained tonsillar hypertrophy. Prompt biopsy, preferably with tonsillectomy and multidisciplinary evaluation, is essential to distinguish this rare entity from other conditions and to guide timely treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.